1,032
Participants
Start Date
February 11, 2020
Primary Completion Date
March 1, 2026
Study Completion Date
May 1, 2026
Roflumilast
Prescription for Roflumilast (250 mcg/day x 4 weeks, then 500 mcg/day or alternate regimen) x 6 to 72 months
Azithromycin
Prescription for Azithromycin (250 mg/day, or 500 mg three times per week, or alternate regimen) x 6 to 72 months
Mount Sinai, New York
Lenox Hill Hospital/Northwell Health, New York
University of Pittsburg Medical Center, Pittsburgh
Temple University Hospital, Philadelphia
Johns Hopkins University, Baltimore
University of North Carolina, School of Medicine, Chapel Hill
Duke, Durham
University of Alabama, Birmingham
Ohio State University, Columbus
University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic, Cleveland
University of Michigan, Ann Arbor
Henry Ford Health System, Detroit
University of Iowa, Iowa City
NorthShore Hospital, Glenview
Northwestern, Chicago
University of Illinois, Chicago, Chicago
University of Missouri, Kansas City, Kansas City
University of Kansas, Kansas City
Ochsner Medical Center, New Orleans
Baylor Scott & White (BSW) Health-North, Dallas
Houston Methodist Hospital, Houston
University of California, Davis Health, Sacramento
Kaiser Permanente, Portland
Providence Health and Services, Spokane
Baystate Health, Springfield
University of Vermont, Burlington
Patient-Centered Outcomes Research Institute
OTHER
University of Illinois at Chicago
OTHER
Johns Hopkins University
OTHER